Researchers identify measure of pulse rate that can predict faster cognitive decline in older adults
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 23-Jul-2025 18:10 ET (23-Jul-2025 22:10 GMT/UTC)
Healthy hearts are adaptable, and heartbeats exhibit complex variation as they adjust to tiny changes in the body and environment. Mass General Brigham researchers have applied a new way to measure the complexity of pulse rates, using data collected through wearable pulse oximetry devices. The new method, published in Journal of the American Heart Association, provides a more detailed peek into heart health than traditional measures, uncovering a link between reduced complexity and future cognitive decline.
The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular disease and prevention, today announced results from the largest study ever conducted of people living with cardiovascular disease who have a confirmed measurement of lipoprotein(a), also known as Lp(a). Results showing that any increase in levels of Lp(a) is associated with increased risk of cardiovascular events including heart attack and stroke were presented today at the European Atherosclerosis Society Congress in Glasgow Scotland and were simultaneously published in the peer-reviewed European Heart Journal.
People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a study of more than a million people published in the European Heart Journal. The protective effect of the vaccine lasts for up to eight years and is particularly pronounced for men, people under the age of 60 and those with unhealthy lifestyles, such as smoking, drinking alcohol and being inactive.
The TCT® Geoffrey O. Hartzler Master Operator Award will be presented to Kenneth Rosenfield, MD, MSc, during Transcatheter Cardiovascular Therapeutics® (TCT®), the annual scientific symposium of the Cardiovascular Research Foundation® (CRF®). TCT® will take place October 25-28, 2025, in San Francisco, California at the Moscone Center. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.
A team of researchers has made a significant breakthrough that could save countless lives in emergencies involving severe blood loss. Their new treatment involves activating a protein called PKC-ε soon after intense bleeding occurs. In their studies, this approach tripled survival rates, increasing them from 25% to an impressive 73%. Additionally, the treatment helped maintain healthy organ function by boosting cellular energy levels, offering hope for improved outcomes in emergency trauma care.